|
1
|
WHO urges more countries to require large,
graphic health warnings on tobacco packaging: the WHO report on the
global tobacco epidemic, 2011 examines anti-tobacco mass-media
campaigns. Cent Eur J Public Health. 19:1331512011.
|
|
2
|
Peters SA, Huxley RR and Woodward M:
Smoking as a risk factor for stroke in women compared with men: a
systematic review and meta-analysis of 81 cohorts, including
3,980,359 individuals and 42,401 strokes. Stroke. 44:2821–2828.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shin VY and Cho CH: Nicotine and gastric
cancer. Alcohol. 35:259–264. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chu KM, Cho CH and Shin VY: Nicotine and
gastrointestinal disorders: its role in ulceration and cancer
development. Curr Pharm Des. 19:5–10. 2013.PubMed/NCBI
|
|
5
|
Peluso ME, Munnia A, Srivatanakul P,
Jedpiyawongse A, Sangrajrang S, Ceppi M, Godschalk RW, van Schooten
FJ and Boffetta P: DNA adducts and combinations of multiple lung
cancer at-risk alleles in environmentally exposed and smoking
subjects. Environ Mol Mutagen. 54:375–383. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jain G and Jaimes EA: Nicotine signaling
and progression of chronic kidney disease in smokers. Biochem
Pharmacol. 86:1215–1223. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li W, Zhou J, Chen L, Luo Z and Zhao Y:
Lysyl oxidase, a critical intra- and extra-cellular target in the
lung for cigarette smoke pathogenesis. Int J Environ Res Public
Health. 8:161–184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang L, Ren JW, Wong CC, Wu WK, Ren SX,
Shen J, Chan RL and Cho CH: Effects of cigarette smoke and its
active components on ulcer formation and healing in the
gastrointestinal mucosa. Curr Med Chem. 19:63–69. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ross R: The pathogenesis of
atherosclerosis: a perspective for the 1990s. Nature. 362:801–809.
1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Hecht SS: Tobacco carcinogens, their
biomarkers and tobacco-induced cancer. Nat Rev Cancer. 3:733–744.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ootani H, Iwakiri R, Shimoda R, Nakahara
S, Amemori S, Fujise T, Kikkawa A, Tsunada S, Sakata H and Fujimoto
K: Role of Helicobacter pylori infection and nonsteroidal
anti-inflammatory drug use in bleeding peptic ulcers in Japan. J
Gastroenterol. 41:41–46. 2006.
|
|
12
|
Garrow D and Delegge MH: Risk factors for
gastrointestinal ulcer disease in the us population. Dig Dis Sci.
55:66–72. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen MH, Wu MS, Lee WC, Wang HP and Lin
JT: A multiple logistic regression analysis of risk factors in
different subtypes of gastric ulcer. Hepatogastroenterology.
49:589–592. 2002.PubMed/NCBI
|
|
14
|
Parasher G and Eastwood GL: Smoking and
peptic ulcer in the Helicobacter pylori era. Eur J
Gastroenterol Hepatol. 12:843–853. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Andersen IB, Jorgensen T, Bonnevie O,
Gronbaek M and Sorensen TI: Smoking and alcohol intake as risk
factors for bleeding and perforated peptic ulcers: a
population-based cohort study. Epidemiology. 11:434–439. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ananthakrishnan AN: Environmental risk
factors for inflammatory bowel disease. Gastroenterol Hepatol (NY).
9:367–374. 2013.PubMed/NCBI
|
|
17
|
Zaharie R, Zaharie F, Mocan L, Andreica V,
Tantau M, Zdrehus C, Iancu C and Tomus C: Surgical outcome of
inflammatory bowel disease - experience of a tertiary center.
Chirurgia (Bucur). 108:812–815. 2013.PubMed/NCBI
|
|
18
|
Lawrance IC, Murray K, Batman B, Gearry
RB, Grafton R, Krishnaprasad K, Andrews JM, Prosser R, Bampton PA,
Cooke SE, Mahy G, et al: Crohn’s disease and smoking: Is it ever
too late to quit? J Crohns Colitis. 7:e665–e671. 2013.
|
|
19
|
Lunney PC and Leong RW: Review article:
Ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol
Ther. 36:997–1008. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Somerville KW, Logan RF, Edmond M and
Langman MJ: Smoking and crohn’s disease. Br Med J (Clin Res Ed).
289:954–956. 1984.
|
|
21
|
Seksik P, Nion-Larmurier I, Sokol H,
Beaugerie L and Cosnes J: Effects of light smoking consumption on
the clinical course of Crohn’s disease. Inflamm Bowel Dis.
15:734–741. 2009.PubMed/NCBI
|
|
22
|
Harries AD, Baird A and Rhodes J:
Non-smoking: A feature of ulcerative colitis. Br Med J (Clin Res
Ed). 284:7061982. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lakatos PL, Vegh Z, Lovasz BD, David G,
Pandur T, Erdelyi Z, Szita I, Mester G, Balogh M, Szipocs I, Molnar
C, et al: Is current smoking still an important environmental
factor in inflammatory bowel diseases? Results from a
population-based incident cohort. Inflamm Bowel Dis. 19:1010–1017.
2013. View Article : Google Scholar
|
|
24
|
Wu WK and Cho CH: The pharmacological
actions of nicotine on the gastrointestinal tract. J Pharmacol Sci.
94:348–358. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Verschuere S, Bracke KR, Demoor T,
Plantinga M, Verbrugghe P, Ferdinande L, Lambrecht BN, Brusselle GG
and Cuvelier CA: Cigarette smoking alters epithelial apoptosis and
immune composition in murine GALT. Lab Invest. 91:1056–1067. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang H, Ma L, Li Y and Cho CH: Exposure to
cigarette smoke increases apoptosis in the rat gastric mucosa
through a reactive oxygen species-mediated and p53-independent
pathway. Free Radic Biol Med. 28:1125–1131. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sharma A, Neekhra A, Gramajo AL, Patil J,
Chwa M, Kuppermann BD and Kenney MC: Effects of Benzo(e)Pyrene, a
toxic component of cigarette smoke, on human retinal pigment
epithelial cells in vitro. Invest Ophthalmol Vis Sci. 49:5111–5117.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
FitzGerald AJ, Mandir N and Goodlad RA:
Leptin, cell proliferation and crypt fission in the
gastrointestinal tract of intravenously fed rats. Cell Prolif.
38:25–33. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Ma L, Wang WP, Chow JY, Yuen ST and Cho
CH: Reduction of EGF is associated with the delay of ulcer healing
by cigarette smoking. Am J Physiol Gastrointest Liver Physiol.
278:G10–G17. 2000.PubMed/NCBI
|
|
30
|
Shin VY, Liu ES, Koo MW, Wang JY, Matsui H
and Cho CH: Cigarette smoke extracts delay wound healing in the
stomach: Involvement of polyamine synthesis. Exp Biol Med
(Maywood). 227:114–124. 2002.PubMed/NCBI
|
|
31
|
Konturek JW, Bielanski W, Konturek SJ,
Bogdal J and Oleksy J: Distribution and release of epidermal growth
factor in man. Gut. 30:1194–1200. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ma L, Wang WP, Chow JY, Lam SK and Cho CH:
The role of polyamines in gastric mucus synthesis inhibited by
cigarette smoke or its extract. Gut. 47:170–177. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Brzozowski T, Konturek SJ, Majka J,
Dembinski A and Drozdowicz D: Epidermal growth factor, polyamines,
and prostaglandins in healing of stress-induced gastric lesions in
rats. Dig Dis Sci. 38:276–283. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Konturek JW, Brzozowski T and Konturek SJ:
Epidermal growth factor in protection, repair, and healing of
gastroduodenal mucosa. J Clin Gastroenterol. 13(Suppl 1): S88–S97.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Maity P, Biswas K, Roy S, Banerjee RK and
Bandyopadhyay U: Smoking and the pathogenesis of gastroduodenal
ulcer - recent mechanistic update. Mol Cell Biochem. 253:329–338.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mertz DP and Thongbhoubesra T: Effect of
nicotine on the production of gastric acid (author’s transl). Med
Klin. 71:147–155. 1976.(In German).
|
|
37
|
Ligny G, Van Ccauter J and Henry JP: The
effect of cigarette smoking on the cicatrization of duodenal ulcers
in patients treated with cimetidine. The role of acid
hypersecretion. Rev Med Brux. 10:233–238. 1989.(In French).
|
|
38
|
Fiddian-Green R, Russell RC and Hobsley M:
Pyloric reflux in duodenal ulceration and its relationship to
smoking. Br J Surg. 60:3211973.PubMed/NCBI
|
|
39
|
Read NW and Grech P: Effect of cigarette
smoking on competence of the pylorus: preliminary study. Br Med J.
3:313–316. 1973. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Valenzuela JE, Defilippi C and Csendes A:
Manometric studies on the human pyloric sphincter. Effect of
cigarette smoking, metoclopramide, and atropine. Gastroenterology.
70:481–483. 1976.PubMed/NCBI
|
|
41
|
Bynum TE, Solomon TE, Johnson LR and
Jacobson ED: Inhibition of pancreatic secretion in man by cigarette
smoking. Gut. 13:361–365. 1972. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Bochenek WJ and Koronczewski R: Effects of
cigarette smoking on bicarbonate and volume of duodenal contents.
Am J Dig Dis. 18:729–733. 1973.PubMed/NCBI
|
|
43
|
Murthy SN, Dinoso VP Jr, Clearfield HR and
Chey WY: Simultaneous measurement of basal pancreatic, gastric acid
secretion, plasma gastrin, and secretin during smoking.
Gastroenterology. 73:758–761. 1977.PubMed/NCBI
|
|
44
|
Deng B, Li Y, Zhang Y, Bai L and Yang P:
Helicobacter pylori infection and lung cancer: a review of
an emerging hypothesis. Carcinogenesis. 34:1189–1195. 2013.
View Article : Google Scholar
|
|
45
|
Bures J, Kopacova M, Skodova Fendrichova M
and Rejchrt S: Epidemiology of Helicobacter pylori
infection. Vnitr Lek. 57:993–999. 2011.(In Czech).
|
|
46
|
Ogihara A, Kikuchi S, Hasegawa A, Kurosawa
M, Miki K, Kaneko E and Mizukoshi H: Relationship between
Helicobacter pylori infection and smoking and drinking
habits. J Gastroenterol Hepatol. 15:271–276. 2000.
|
|
47
|
Arkkila PE, Kokkola A, Seppälä K and
Sipponen P: Size of the peptic ulcer in Helicobacter
pylori-positive patients: association with the clinical and
histological characteristics. Scand J Gastroenterol. 42:695–701.
2007.PubMed/NCBI
|
|
48
|
Endoh K and Leung FW: Effects of smoking
and nicotine on the gastric mucosa: a review of clinical and
experimental evidence. Gastroenterology. 107:864–878. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Smith SM and Kvietys PR: Gastric ulcers:
Role of oxygen radicals. Crit Care Med. 16:892–898. 1988.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hirota M, Inoue M, Ando Y and Morino Y:
Inhibition of stress-induced gastric mucosal injury by a long
acting superoxide dismutase that circulates bound to albumin. Arch
Biochem Biophys. 280:269–273. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Calvino Fernández M and Parra Cid T: H.
pylori and mitochondrial changes in epithelial cells. The role
of oxidative stress. Rev Esp Enferm Dig. 102:41–50. 2010.
|
|
52
|
Church DF and Pryor WA: Free-radical
chemistry of cigarette smoke and its toxicological implications.
Environ Health Perspect. 64:111–126. 1985. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kalra J, Chaudhary AK and Prasad K:
Increased production of oxygen free radicals in cigarette smokers.
Int J Exp Pathol. 72:1–7. 1991.PubMed/NCBI
|
|
54
|
Sopori M: Effects of cigarette smoke on
the immune system. Nat Rev Immunol. 2:372–377. 2002. View Article : Google Scholar
|
|
55
|
Chow JY, Ma L and Cho CH: Involvement of
free radicals and histamine in the potentiating action of cigarette
smoke exposure on ethanol-induced gastric mucosal damage in rats.
Free Radic Biol Med. 24:1285–1293. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar
|
|
57
|
Tang Y, Kassie F, Qian X, Ansha B and
Turesky RJ: DNA adduct formation of 2-amino-9H-pyrido[2,3-b)indole
and 2-amino-3,4-dimethylimidazo[4,5-f)quinoline in mouse liver and
extrahepatic tissues during a subchronic feeding study. Toxicol
Sci. 133:248–258. 2013.
|
|
58
|
Martin JW, Mousa SS, Shaker O and Mousa
SA: The multiple faces of nicotine and its implications in tissue
and wound repair. Exp Dermatol. 18:497–505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Zong Y, Zhang ST and Zhu ST: Nicotine
enhances migration and invasion of human esophageal squamous
carcinoma cells which is inhibited by nimesulide. World J
Gastroenterol. 15:2500–2505. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Cucina A, Dinicola S, Coluccia P, Proietti
S, D’Anselmi F, Pasqualato A and Bizzarri M: Nicotine stimulates
proliferation and inhibits apoptosis in colon cancer cell lines
through activation of survival pathways. J Surg Res. 178:233–241.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Seitz HK and Cho CH: Contribution of
alcohol and tobacco use in gastrointestinal cancer development.
Methods Mol Biol. 472:217–241. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Castellsagué X, Muñoz N, De Stefani E,
Victora CG, Castelletto R, Rolón PA and Quintana MJ: Independent
and joint effects of tobacco smoking and alcohol drinking on the
risk of esophageal cancer in men and women. Int J Cancer.
82:657–664. 1999.PubMed/NCBI
|
|
63
|
Freedman ND, Abnet CC, Leitzmann MF, Mouw
T, Subar AF, Hollenbeck AR and Schatzkin A: A prospective study of
tobacco, alcohol, and the risk of esophageal and gastric cancer
subtypes. Am J Epidemiol. 165:1424–1433. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yaegashi Y, Onoda T, Morioka S, Hashimoto
T, Takeshita T, Sakata K and Tamakoshi A: Joint effects of smoking
and alcohol drinking on esophageal cancer mortality in Japanese
men: Findings from the Japan collaborative cohort study. Asian Pac
J Cancer Prev. 15:1023–1029. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Brown LM, Hoover R, Silverman D, Baris D,
Hayes R, Swanson GM, Schoenberg J, Greenberg R, Liff J, Schwartz A,
Dosemeci M, et al: Excess incidence of squamous cell esophageal
cancer among US Black men: role of social class and other risk
factors. Am J Epidemiol. 153:114–122. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Radoï L, Paget-Bailly S, Cyr D,
Papadopoulos A, Guida F, Schmaus A, Cénée S, Menvielle G, Carton M,
Lapôtre-Ledoux B, Delafosse P, et al: Tobacco smoking, alcohol
drinking and risk of oral cavity cancer by subsite: results of a
French population-based case-control study, the ICARE study. Eur J
Cancer Prev. 22:268–276. 2013.PubMed/NCBI
|
|
67
|
Pentenero M, Giaretti W, Navone R, Rostan
I, Gassino L, Broccoletti R, Arduino PG, Malacarne D and Gandolfo
S: Evidence for a possible anatomical subsite-mediated effect of
tobacco in oral potentially malignant disorders and carcinoma. J
Oral Pathol Med. 40:214–217. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Muwonge R, Ramadas K, Sankila R, Thara S,
Thomas G, Vinoda J and Sankaranarayanan R: Role of tobacco smoking,
chewing and alcohol drinking in the risk of oral cancer in
Trivandrum, India: a nested case-control design using incident
cancer cases. Oral Oncol. 44:446–454. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Sasazuki S, Sasaki S and Tsugane S:
Cigarette smoking, alcohol consumption and subsequent gastric
cancer risk by subsite and histologic type. Int J Cancer.
101:560–566. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Moy KA, Fan Y, Wang R, Gao YT, Yu MC and
Yuan JM: Alcohol and tobacco use in relation to gastric cancer: a
prospective study of men in Shanghai, China. Cancer Epidemiol
Biomarkers Prev. 19:2287–2297. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
Eguchi H and Nakachi K: Smoking as a risk
factor for pancreatic cancer. Nihon Rinsho. 64(Suppl 1): S10–S13.
2006.(In Japanese).
|
|
72
|
Yun JE, Jo I, Park J, Kim MT, Ryu HG,
Odongua N, Kim E and Jee SH: Cigarette smoking, elevated fasting
serum glucose, and risk of pancreatic cancer in korean men. Int J
Cancer. 119:208–212. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Farris SM, Pettrey C and Daly KC: A
subpopulation of mushroom body intrinsic neurons is generated by
protocerebral neuroblasts in the tobacco hornworm moth, Manduca
sexta (Sphingidae, Lepidoptera). Arthropod Struct Dev.
40:395–408. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Phipps AI, Shi Q, Newcomb PA, Nelson GD,
Sargent DJ, Alberts SR and Limburg PJ: Associations between
cigarette smoking status and colon cancer prognosis among
participants in North Central Cancer Treatment Group Phase III
Trial N0147. J Clin Oncol. 31:2016–2023. 2013. View Article : Google Scholar
|
|
75
|
Schuller HM: Is cancer triggered by
altered signalling of nicotinic acetylcholine receptors? Nat Rev
Cancer. 9:195–205. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Zhao Y, Zhou W, Xue L, Zhang W and Zhan Q:
Nicotine activates YAP1 through nAChRs mediated signaling in
esophageal squamous cell cancer (ESCC). PLoS One. 9:e908362014.
View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Chernyavsky AI, Arredondo J, Vetter DE and
Grando SA: Central role of alpha9 acetylcholine receptor in
coordinating keratinocyte adhesion and motility at the initiation
of epithelialization. Exp Cell Res. 313:3542–3555. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Wong HP, Yu L, Lam EK, Tai EK, Wu WK and
Cho CH: Nicotine promotes cell proliferation via alpha7-nicotinic
acetylcholine receptor and catecholamine-synthesizing
enzymes-mediated pathway in human colon adenocarcinoma ht-29 cells.
Toxicol Appl Pharmacol. 221:261–267. 2007. View Article : Google Scholar
|
|
79
|
Wong HP, Yu L, Lam EK, Tai EK, Wu WK and
Cho CH: Nicotine promotes colon tumor growth and angiogenesis
through beta-adrenergic activation. Toxicol Sci. 97:279–287. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Jarabek AM, Pottenger LH, Andrews LS,
Casciano D, Embry MR, Kim JH, Preston RJ, Reddy MV, Schoeny R,
Shuker D, Skare J, et al: Creating context for the use of DNA
adduct data in cancer risk assessment: I. Data organization. Crit
Rev Toxicol. 39:659–678. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Dyke GW, Craven JL, Hall R and Garner RC:
Smoking-related DNA adducts in human gastric cancers. Int J Cancer.
52:847–850. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Bartsch H, Ohshima H, Pignatelli B and
Calmels S: Human exposure to endogenous N-nitroso compounds:
quantitative estimates in subjects at high risk for cancer of the
oral cavity, oesophagus, stomach and urinary bladder. Cancer Surv.
8:335–362. 1989.PubMed/NCBI
|
|
83
|
Pabiszczak M, Szmeja Z, Szyfter K and
Szyfter W: Analysis of aromatic DNA adducts in oral cavity and
pharyngeal cancer. Otolaryngol Pol. 54:151–156. 2000.(In
Polish).
|
|
84
|
Lee JM, Liu TY, Wu DC, Tang HC, Leh J, Wu
MT, Hsu HH, Huang PM, Chen JS, Lee CJ and Lee YC: Safrole-DNA
adducts in tissues from esophageal cancer patients: Clues to
areca-related esophageal carcinogenesis. Mutat Res. 565:121–128.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Wang M, Abbruzzese JL, Friess H, Hittelman
WN, Evans DB, Abbruzzese MC, Chiao P and Li D: DNA adducts in human
pancreatic tissues and their potential role in carcinogenesis.
Cancer Res. 58:38–41. 1998.PubMed/NCBI
|
|
86
|
Al-Saleh I, Arif J, El-Doush I, Al-Sanea
N, Jabbar AA, Billedo G, Shinwari N, Mashhour A and Mohamed G:
Carcinogen DNA adducts and the risk of colon cancer: case-control
study. Biomarkers. 13:201–216. 2008. View Article : Google Scholar
|
|
87
|
Hecht SS: Recent studies on mechanisms of
bioactivation and detoxification of
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a
tobacco-specific lung carcinogen. Crit Rev Toxicol. 26:163–181.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Belinsky SA, Devereux TR, Maronpot RR,
Stoner GD and Anderson MW: Relationship between the formation of
promutagenic adducts and the activation of the K-ras protooncogene
in lung tumors from A/J mice treated with nitrosamines. Cancer Res.
49:5305–5311. 1989.PubMed/NCBI
|
|
89
|
Askari MD, Tsao MS and Schuller HM: The
tobacco-specific carcinogen,
4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone stimulates
proliferation of immortalized human pancreatic duct epithelia
through beta-adrenergic transactivation of EGF receptors. J Cancer
Res Clin Oncol. 131:639–648. 2005. View Article : Google Scholar
|
|
90
|
Colotta F, Allavena P, Sica A, Garlanda C
and Mantovani A: Cancer-related inflammation, the seventh hallmark
of cancer: links to genetic instability. Carcinogenesis.
30:1073–1081. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
91
|
Liu ES, Ye YN, Shin VY, Yuen ST, Leung SY,
Wong BC and Cho CH: Cigarette smoke exposure increases ulcerative
colitis-associated colonic adenoma formation in mice.
Carcinogenesis. 24:1407–1413. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
van Horssen R, Ten Hagen TL and Eggermont
AM: TNF-alpha in cancer treatment: molecular insights, antitumor
effects, and clinical utility. Oncologist. 11:397–408.
2006.PubMed/NCBI
|
|
93
|
Wheelhouse NM, Chan YS, Gillies SE,
Caldwell H, Ross JA, Harrison DJ and Prost S: TNF-α induced DNA
damage in primary murine hepatocytes. Int J Mol Med. 12:889–894.
2003.
|
|
94
|
Charles KA, Kulbe H, Soper R,
Escorcio-Correia M, Lawrence T, Schultheis A, Chakravarty P,
Thompson RG, Kollias G, Smyth JF, Balkwill FR and Hagemann T: The
tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in
ovarian cancer in mice and humans. J Clin Invest. 119:3011–3023.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
95
|
Idriss HT and Naismith JH: TNF alpha and
the TNF receptor superfamily: structure-function relationship(s).
Microsc Res Tech. 50:184–195. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Oguma K, Oshima H, Aoki M, Uchio R, Naka
K, Nakamura S, Hirao A, Saya H, Taketo MM and Oshima M: Activated
macrophages promote Wnt signalling through tumour necrosis
factor-alpha in gastric tumour cells. EMBO J. 27:1671–1681. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
97
|
Chang YC, Chen TC, Lee CT, Yang CY, Wang
HW, Wang CC and Hsieh SL: Epigenetic control of MHC class II
expression in tumor-associated macrophages by decoy receptor 3.
Blood. 111:5054–5063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
98
|
Chung YC and Chang YF: Serum interleukin-6
levels reflect the disease status of colorectal cancer. J Surg
Oncol. 83:222–226. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Tebbutt NC, Giraud AS, Inglese M, Jenkins
B, Waring P, Clay FJ, Malki S, Alderman BM, Grail D, Hollande F,
Heath JK and Ernst M: Reciprocal regulation of gastrointestinal
homeostasis by SHP2 and STAT-mediated trefoil gene activation in
gp130 mutant mice. Nat Med. 8:1089–1097. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Schneider MR, Hoeflich A, Fischer JR, Wolf
E, Sordat B and Lahm H: Interleukin-6 stimulates clonogenic growth
of primary and metastatic human colon carcinoma cells. Cancer Lett.
151:31–38. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Becker C, Fantini MC, Schramm C, Lehr HA,
Wirtz S, Nikolaev A, Burg J, Strand S, Kiesslich R, Huber S, Ito H,
et al: TGF-beta suppresses tumor progression in colon cancer by
inhibition of IL-6 trans-signaling. Immunity. 21:491–501. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Candido J and Hagemann T: Cancer-related
inflammation. J Clin Immunol. 33(Suppl 1): S79–S84. 2013.
View Article : Google Scholar
|
|
103
|
Luo JL, Tan W, Ricono JM, Korchynskyi O,
Zhang M, Gonias SL, Cheresh DA and Karin M: Nuclear
cytokine-activated IKKalpha controls prostate cancer metastasis by
repressing Maspin. Nature. 446:690–694. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Krelin Y, Voronov E, Dotan S, Elkabets M,
Reich E, Fogel M, Huszar M, Iwakura Y, Segal S, Dinarello CA and
Apte RN: Interleukin-1beta-driven inflammation promotes the
development and invasiveness of chemical carcinogen-induced tumors.
Cancer Res. 67:1062–1071. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Voronov E, Shouval DS, Krelin Y, Cagnano
E, Benharroch D, Iwakura Y, Dinarello CA and Apte RN: IL-1 is
required for tumor invasiveness and angiogenesis. Proc Natl Acad
Sci USA. 100:2645–2650. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Carmi Y, Dotan S, Rider P, Kaplanov I,
White MR, Baron R, Abutbul S, Huszar M, Dinarello CA, Apte RN and
Voronov E: The role of IL-1β in the early tumor cell-induced
angiogenic response. J Immunol. 190:3500–3509. 2013.
|
|
107
|
Dimberg A: Chemokines in angiogenesis.
Curr Top Microbiol Immunol. 341:59–80. 2010.
|
|
108
|
Wilson J and Balkwill F: The role of
cytokines in the epithelial cancer microenvironment. Semin Cancer
Biol. 12:113–120. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Wang D, Wang H, Brown J, Daikoku T, Ning
W, Shi Q, Richmond A, Strieter R, Dey SK and DuBois RN: CXCL1
induced by prostaglandin E2 promotes angiogenesis in colorectal
cancer. J Exp Med. 203:941–951. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Erreni M, Bianchi P, Laghi L, Mirolo M,
Fabbri M, Locati M, Mantovani A and Allavena P: Expression of
chemokines and chemokine receptors in human colon cancer. Methods
Enzymol. 460:105–121. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Gales D, Clark C, Manne U and Samuel T:
The chemokine CXCL8 in carcinogenesis and drug response. ISRN
Oncol. 2013:8591542013.PubMed/NCBI
|
|
112
|
Vandercappellen J, Van Damme J and Struyf
S: The role of CXC chemokines and their receptors in cancer. Cancer
Lett. 267:226–244. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
113
|
Luppi F, Longo AM, de Boer WI, Rabe KF and
Hiemstra PS: Interleukin-8 stimulates cell proliferation in
non-small cell lung cancer through epidermal growth factor receptor
transactivation. Lung Cancer. 56:25–33. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
114
|
Richardson RM, Ali H, Pridgen BC, Haribabu
B and Snyderman R: Multiple signaling pathways of human
interleukin-8 receptor A. Independent regulation by
phosphorylation. J Biol Chem. 273:10690–10695. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Inoue K, Slaton JW, Eve BY, Kim SJ,
Perrotte P, Balbay MD, Yano S, Bar-Eli M, Radinsky R, Pettaway CA
and Dinney CP: Interleukin 8 expression regulates tumorigenicity
and metastases in androgen-independent prostate cancer. Clin Cancer
Res. 6:2104–2119. 2000.PubMed/NCBI
|
